Richard G. Ghalie - 29 Sep 2023 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Chief Medical Officer
Signature
/s/ David M. Urso, as attorney in fact
Issuer symbol
MEIP
Transactions as of
29 Sep 2023
Net transactions value
$0
Form type
4
Filing time
12 Oct 2023, 19:38:45 UTC
Previous filing
07 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 29 Sep 2023 Common Stock 30,000 $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024.